Concomitant inhibition of receptor tyrosine kinases and downstream AKT synergistically inhibited growth of KRAS/BRAF mutant colorectal cancer cells

Qiaoling Song(Marine Biomedical Research Institute of Qingdao), Qiang Yu(Fudan University)
Oncotarget
December 17, 2016
Cited by 19


Related Papers